🔎 Trials Near Me

Akèy › Myelofibroz › Maryland › Baltimore

Etid klinik pou Myelofibroz nan Baltimore, MD

7 etid pou Myelofibroz ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Ap rekriteFaz 1/2
  • University of Maryland, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04176198

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Johns Hopkins University, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • John Hopkins Hospital, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Johns Hopkins Hospital, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Towson · 8 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Ap rekriteFaz 3
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2025 · NCT06479135

Etid Myelofibroz nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.